FDA Approves Rapid-acting insulin lispro-aabc Injection for Pump Therapy

FDA Approves Rapid-acting insulin lispro-aabc Injection for Pump Therapy

Previously Published on Healio.com  – The FDA approved an expanded label for rapid-acting insulin lispro-aabc injection to include administration via continuous subcutaneous infusion with an insulin pump, according to an industry press release. As Healio previously reported, insulin lispro-aabc injection (Lyumjev, Eli Lilly), a novel formulation of insulin lispro developed to speed the absorption of…

Switched to Tandem's t:slim X2 with Dexcom G6

Switched to Tandem’s t:slim X2 insulin pump – Dexcom G6

For the past 2+ years I’ve been using the Minimed 670g insulin pump system for my diabetes treatment. However, I found the guardian CGM was very inaccurate. There were times when my blood sugar readings were off by more than 50 points. And this occurred at times when I didn’t eat for hours (stable blood…

Medtronic Recall

Medtronic Recall: MiniMed 600 Series Insulin Pumps Faulty Retainer Ring

ALERT: Medtronic Recall 600 Series Insulin Pumps The FDA has issued a class 1 recall on Medtronic’s 600 series Minimed insulin pumps due to a missing or broken retainer ring. The faulty retainer ring causes over or under insulin dosing. The retainer ring keeps the insulin cartridge firmly locked into the pump. There has been…

Beta Bionics granted FDA Breakthrough Device Designation for iLet Bionic Pancreas System
|

Beta Bionics granted FDA Breakthrough Device Designation for iLet Bionic Pancreas System

Today Beta Bionics was granted FDA breakthrough device designation for the iLet bionic pancreas system. The designation was granted in all configurations of the iLet (insulin-only, glucagon-only and bihormonal). The meaning of FDA breakthrough device designation is to provide patients and health care providers with timely access to medical devices by speeding up their development, assessment, and review….

bihormonal ilet home trial by Beta Bionics

Bihormonal iLet Home Trial Bionic Pancreas for T1D

Beta Bionics announced a pivotal bihormonal iLet home trial using both dasiglucagon and insulin in the aforementioned bionic pancreas. The iLet (dual-hormone pump system) designed to autonomously deliver insulin and dasiglucagon. The bionic pancreas offers people with type 1 diabetes, safer and easier blood sugar control. Therefore, better long-term management and outcomes are possible as well. What is…

Closed Loop Insulin Pump System

Medtronic Receives FDA Device Designation for Closed Loop Insulin Pump System

Today Medtronic announced it has received FDA breakthrough device designation for its (PLC) personalized closed loop insulin pump system. It is currently in the development stage. The technology is designed to automate insulin delivery in real-time while personalized and adapts to the user. The system will also provide insights and predictive diagnostics unique to the individual, the goal…

Prof. Henrik Semb explains New Research Generates Insulin Producing Cells
|

Insulin Producing Cells Generated in New Research

A new research generates insulin producing cells in a study from the University of Copenhagen in Denmark and the Helmholtz Zentrum München in Neuherberg, Germany. Read the full article here! Watch Prof. Henrik Semb explain the research in this video! Read about new human stem cell research which cured mice of diabetes!